Playing Down The Risks Of A Billion-Dollar Drug

Playing Down The Risks Of A Billion-Dollar Drug

By the beginning of 1999, Johnson & Johnson had expanded the ElderCare unit to 136 salespeople from 83, and the materials they were using to pitch doctors had caught the FDA’s eye.

Popular in the Community

Close

HuffPost Shopping’s Best Finds

MORE IN LIFE